Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Socié, Gérard, Milpied, Noel, Yakoub-Agha, Ibrahim, Bay, Jacques-Olivier, Fürst, Sabine, Bilger, Karin, Suarez, Felipe, Michallet, Mauricette, Lewalle, Philippe, Liens, David, Mathis, Catherine, Guemas, Eric, Vernant, Jean-Paul
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2019
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341192/
https://ncbi.nlm.nih.gov/pubmed/30670534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018028282
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars